Exchange Traded Concepts’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$732K Sell
67,169
-6,551
-9% -$81.8K 0.01% 937
2025
Q4
$953K Buy
73,720
+9,621
+15% +$124K 0.01% 827
2025
Q3
$828K Buy
64,099
+22,383
+54% +$299K 0.01% 853
2025
Q2
$743K Buy
41,716
+3,904
+10% +$68K 0.01% 809
2025
Q1
$674K Buy
37,812
+9,001
+31% +$204K 0.01% 732
2024
Q4
$859K Sell
28,811
-19,616
-41% -$415K 0.02% 623
2024
Q3
$757K Buy
48,427
+8,272
+21% +$150K 0.02% 657
2024
Q2
$688K Sell
40,155
-18,775
-32% -$330K 0.02% 577
2024
Q1
$921K Sell
58,930
-14,829
-20% -$218K 0.02% 452
2023
Q4
$1.1M Buy
73,759
+22,627
+44% +$303K 0.03% 385
2023
Q3
$826K Buy
51,132
+34,289
+204% +$989K 0.02% 424
2023
Q2
$699K Sell
16,843
-983
-6% -$61K 0.02% 477
2023
Q1
$1.07M Sell
17,826
-299
-2% -$23.9K 0.03% 318
2022
Q4
$1.33M Buy
18,125
+368
+2% +$27.7K 0.04% 259
2022
Q3
$1.35M Sell
17,757
-4,089
-19% -$319K 0.04% 205
2022
Q2
$1.52M Sell
21,846
-10,189
-32% -$768K 0.04% 210
2022
Q1
$2.65M Sell
32,035
-2,826
-8% -$208K 0.05% 183
2021
Q4
$2.62M Buy
34,861
+20,985
+151% +$2.11M 0.05% 218
2021
Q3
$1.61M Buy
13,876
+3,215
+30% +$486K 0.04% 249
2021
Q2
$2.37M Sell
10,661
-2,505
-19% -$487K 0.07% 210
2021
Q1
$1.74M Buy
13,166
+5,837
+80% +$923K 0.07% 211
2020
Q4
$1.27M Sell
7,329
-1,997
-21% -$273K 0.06% 201
2020
Q3
$1.04M Buy
9,326
+3,282
+54% +$262K 0.06% 164
2020
Q2
$358K Buy
6,044
+4,370
+261% +$287K 0.06% 265
2020
Q1
$113K Buy
1,674
+1,103
+193% +$87.2K 0.06% 249
2019
Q4
$48K Buy
+571
New +$46.1K 0.01% 279

Other funds holding NVCR